John Whitney, Director, Fertility Storage Solutions, an Ovation Company
A skilled program and product developer with more than a decade of hands-on IVF lab experience, John Whitney has spent his career expanding his expertise in the science and management of all aspects of fertility care. Having held leadership roles in both IVF and genetics laboratories, as well as in egg donation and cryopreservation services, Mr. Whitney is dedicated to helping more people create their families through advanced fertility care services.
Mr. Whitney began his career in fertility care as an embryologist, spending more than a decade working in an IVF laboratory, advancing the science of third-party reproduction and teaching blastocyst biopsy techniques worldwide. He joined the business development team of Ovation® Fertility in 2016, where he helped develop Ovation Genetics into its current role as an industry leader. In 2017, Ovation enlisted his program development skills to build Ovation’s Donor Services program from the ground up.
A year later, Mr. Whitney took the lead overseeing another new program: Fertility Storage Solutions, an Ovation company. FSS includes cryostorage facilities within multiple IVF labs, as well as a dedicated off-site storage facility. Today, in his director role with FSS, he manages a team of professionals overseeing storage, transport and alarm monitoring for all reproductive specimens stored within the Ovation network.
In recent years, he has also guided the development of several Ovation service lines, including the Center for Surrogate Parenting and Ovation Donor Services.
He presented his research on improving outcomes utilizing PGT-A, embryology culture and morphology at multiple worldwide scientific events, including the American Society for Reproductive Medicine Scientific Congress and Expo (ASRM), European Society of Human Reproduction and Embryology Annual Meeting (ESHRE), the Preimplantation Genetic Diagnosis International Society Congress (PGDIS), and the Universal Egyptian Assisted Reproductive Technology Summit (UEARS).
Mr. Whitney graduated from California Polytechnic University San Luis Obispo, where he studied animal science and applied biotechnology. While a student, he worked for Santa Cruz Biotech in its polyclonal antibody production lab, then started his career in clinical human embryology after graduation. Early in his career, he was part of a group of thought leaders supported by Illumina Co. to educate and train other scientists on PGT-A embryology techniques.